Application Nr Approved Date Route Status External Links
NDA021689 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nexium I.v. Is A Proton Pump Inhibitor (Ppi) Indicated For The: • Short-Term Treatment Of Gastroesophageal Reflux Disease (Gerd) With Erosive Esophagitis (Ee) In Adults And Pediatric Patients 1 Month To 17 Years Of Age, As An Alternative To Oral Therapy When Oral Nexium Is Not Possible Or Appropriate. (1.1) • Risk Reduction Of Rebleeding Of Gastric Or Duodenal Ulcers Following Therapeutic Endoscopy For Acute Bleeding Gastric Or Duodenal Ulcers In Adults. (1.2) 1.1 Treatment Of Gastroesophageal Reflux Disease (Gerd) With Erosive Esophagitis (Ee) Nexium I.v. Is Indicated For The Short-Term Treatment Of Gerd With Ee In Adults And Pediatric Patients 1 Month To 17 Years, Inclusively As An Alternative To Oral Therapy When Oral Nexium Is Not Possible Or Appropriate. 1.2 Risk Reduction Of Rebleeding Of Gastric Or Duodenal Ulcers Following Therapeutic Endoscopy In Adults Nexium I.v. Is Indicated For Risk Reduction Of Rebleeding Of Gastric Or Duodenal Ulcers Following Therapeutic Endoscopy For Acute Bleeding Gastric Or Duodenal Ulcers In Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Esomeprazole Sodium ESOMEPRAZOLE SODIUM ZINC4693574

Comments